CVE-2024-10476: high-severity vulnerability in Becton Dickinson & Co BD BACTEC™ Blood Culture…
Published
E-mail alert when it lands in KEV, gets a public PoC or its score goes up.
21Vexday Risk Score
No sign of exploitation. No public exploitation artifact known so far.
ssvc Trackcvss 8epss 0.2%
Default credentials are used in the above listed BD Diagnostic Solutions products. If exploited, threat actors may be able to access, modify or delete data, including sensitive information such as protected health information (PHI) and personally identifiable information (PII). Exploitation of this vulnerability may allow an attacker to shut down or otherwise impact the availability of the system. Note: BD Synapsys™ Informatics
Solution is only in scope of
this vulnerability when
installed on a NUC server. BD Synapsys™
Informatics Solution installed
on a customer-provided virtual machine or on the BD Kiestra™ SCU hardware is
not in scope.
CVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Affected products
Becton Dickinson & Co · BD BACTEC™ Blood Culture SystemBecton Dickinson & Co · BD COR™ SystemBecton Dickinson & Co · BD EpiCenter™ Microbiology Data Management SystemBecton Dickinson & Co · BD MAX™ SystemBecton Dickinson & Co · BD Phoenix™ M50 Automated Microbiology SystemBecton Dickinson & Co · BD Synapsys™ Informatics Solution